Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Common discriminative stimulus properties in rats of muscarinic antagonists, clozapine and the D-3 preferring antagonist PNU-99194A: an analysis of possible mechanisms
Autore:
Goudie, AJ; Baker, LE; Smith, JA; Prus, AJ; Svensson, KA; Cortes-Burgos, LA; Wong, EHF; Haadsma-Svensson, S;
Indirizzi:
Univ Liverpool, Dept Psychol, Liverpool L69 7ZA, Merseyside, England Univ Liverpool Liverpool Merseyside England L69 7ZA , Merseyside, England Western Michigan Univ, Dept Psychol, Kalamazoo, MI 49008 USA Western Michigan Univ Kalamazoo MI USA 49008 hol, Kalamazoo, MI 49008 USA Pharmacia Corp, Neurobiol Res, Kalamazoo, MI USA Pharmacia Corp KalamazooMI USA a Corp, Neurobiol Res, Kalamazoo, MI USA Pharmacia Corp, Struct Analyt & Med Chem, Kalamazoo, MI USA Pharmacia Corp Kalamazoo MI USA uct Analyt & Med Chem, Kalamazoo, MI USA
Titolo Testata:
BEHAVIOURAL PHARMACOLOGY
fascicolo: 5, volume: 12, anno: 2001,
pagine: 303 - 315
SICI:
0955-8810(200109)12:5<303:CDSPIR>2.0.ZU;2-F
Fonte:
ISI
Lingua:
ENG
Soggetto:
WILD-TYPE MICE; RECEPTOR ANTAGONIST; ANTIPSYCHOTIC-DRUGS; PHARMACOLOGICAL CHARACTERIZATION; LOCOMOTOR-ACTIVITY; MESSENGER-RNA; IN-VIVO; DOPAMINE; D3; AGONISTS;
Keywords:
drug discrimination; rat; dopamine; clozapine; schizophrenia; D-3-preferring antagonists; PNU-99194A; scopolamine; trihexyphenidyl; receptor binding;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Life Sciences
Citazioni:
46
Recensione:
Indirizzi per estratti:
Indirizzo: Goudie, AJ Univ Liverpool, Dept Psychol, Bedford St, Liverpool L69 7ZA, Merseyside, England Univ Liverpool Bedford St Liverpool Merseyside England L69 7ZA
Citazione:
A.J. Goudie et al., "Common discriminative stimulus properties in rats of muscarinic antagonists, clozapine and the D-3 preferring antagonist PNU-99194A: an analysis of possible mechanisms", BEHAV PHARM, 12(5), 2001, pp. 303-315

Abstract

Dopamine D-3 receptors have been implicated in the aetiology of schizophrenia and the actions of antipsychotic drugs. The initial studies reported here assessed the involvement of such receptors in the in vivo actions of theatypical antipsychotic clozapine and the putative D-3-preferring antagonist PNU-99194A in drug discrimination assays. Rats trained to discriminate clozapine consistently generalized to PNU-99194A in two separate studies. However, four other putative D-3-preferring antagonists (PD 152255, (+)-S14297, nafadotride and (+)-AJ 76) did not induce generalization to clozapine. Inrats trained to discriminate PNU-99194A, which has been suggested to induce a stimulus mediated specifically by D3 antagonism, the D3-preferring antagonist (+)-UH 232 and clozapine both induced full generalization. However, the PNU-99194A-trained animals also generalized fully to the muscarinic antagonists scopolamine and trihexyphenidyl. A possible explanation for the symmetrical generalization observed between clozapine and PNU-99194A is that these drugs have common muscarinic antagonist actions, since muscarinic antagonists have been reported to substitute for clozapine in numerous prior studies. However, in vitro receptor binding studies with M-1-M-5 receptors indicated that (with the possible exception of the M-4 receptor), no muscarinic receptor subtype had high affinity for both clozapine, PNU-99194A and scopolamine. In addition, other binding studies indicated that whereas clozapine and PNU-99194A had high affinity for the D3 receptor, scopolamine did not. It is therefore concluded that: (1) The generalization seen between clozapine, PNU-99194A and muscarinic antagonists may be mediated by common effects 'downstream' from either muscarinic or D-3 receptors; (2) D-3 antagonism does not play a critical role in the clozapine stimulus (since D-3-preferring antagonists did not consistently induce generalization to clozapine); (3) although D-3 antagonism plays a role in the PNU-91994A stimulus (since the D-3-preferring antagonist (+)-UH 232 induced full generalization, in accord with results from prior studies with other D3-preferring antagonists, the PNU-99194A stimulus also has commonalities with that induced by muscarinic antagonists and clozapine. The in vivo differences observed between PNU-99194A and other D-3-preferring antagonists should be borne in mind whenthis agent is used as a tool to study D-3 receptor functioning in vivo. The similarities between the PNU-99194A and clozapine stimuli suggest tentatively that compounds with a profile like PNU-99194A may have antipsychotic actions similar to clozapine. Some preclinical data are suggestive of such effects of PNU-99194A. (C) 2001 Lippincott Williams & Wilkins.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 19/01/20 alle ore 20:23:17